Economy

From e-cigarettes to lab devices: surprising facts about Swiss patents

Men standing in front of a spherical vehicle, in black and white

This content was published on Apr 15, 2026 Switzerland is the most innovative country in Europe in terms of patents. The five most exciting points about the latest statistics.

A campaign to allow a limited "Right to Be Forgotten" is trying to provide better financial security for thousands of former cancer patients.

Health systems

Cured but uninsurable: the hidden financial burden of surviving cancer in Switzerland

This content was published on Apr 15, 2026 More people are surviving cancer than ever before. But in Switzerland a historical diagnosis can follow former patients for years.

Agribusiness

How the war in Iran is affecting the Swiss food industry

This content was published on Apr 9, 2026 From chocolate sales at airports to fertiliser trade bottlenecks – the Swiss food and commodity industry is already feeling the impact of the war in the Middle East.

Schizophrenia Brain of MRI scan data for child onset schizophrenia showing areas of brain growth and loss of tissue .

AI and medicine

A brain scan before a prescription? Geneva’s bet on precision psychiatry

This content was published on Apr 4, 2026 Swiss scientists are hoping a simple brain scan can revolutionise treatment of mental illnesses.

Agribusiness

Swiss eat more than 23kg of cheese on average

This content was published on Apr 2, 2026 In Switzerland total consumption of cheese, both domestic and imported, rose by more than 7,000 tonnes in 2025 compared with the previous year.

US towards imposition of 100% duties on certain drugs

Trade policy

US expected to impose 100% tariffs on certain drugs: report

This content was published on Apr 2, 2026 The United States is preparing to impose 100% tariffs on certain drugs of pharma companies that haven't reached an agreement with the White House, the Financial Times reports.

New treatments

Can Swiss pharma giant Roche reshape the obesity market?

This content was published on Apr 2, 2026 Swiss pharmaceutical firm Roche is investing billions in new obesity treatments in hopes of breaking into a highly competitive market.